Factors Associated with Early Death in Patients with Community-Acquired Pneumonia

Background : Early death is an important problem associated with the management of community-acquired pneumonia. However, there is little information on the risk factors associated with it. The aim of this study was to identify the factors associated with early death in community-acquired pneumonia patients. Methods : From January 1999 to July 2004, 1,487 adult patients with community-acquired pneumonia who were admitted to the pulmonary department via emergency center were examined. Early death was defined as those who died within 2 days of hospitalization. The clinical and laboratory aspects of the patients who died early (n = 30) were compared with those of an age and gender matched control population (n = 60) . Results : In the early death group, respiratory rate, heart rate, and blood urea nitrogen (BUN) were significant higher (p < 0.05 for all), while the arterial pH, systolic pressure, and PaO2 were significant lower (p < 0.05 for all) than the control. The independent factor significantly associated with early death was tachypnea (OR, 7.049). Conclusion : The importance of an early clinical assessment in emergency center with community-acquired pneumonia needs to be emphasized in order to recognize patients at risk of early death. (Tuberc Respir Dis 2005; 58: 607-613)

keywords: Community-acquired pneumonia, Clinical manifestation, Tachypnea, Community-acquired pneumonia, Clinical manifestation, Tachypnea

Reference

(2001) Deaths:preliminary data for 2000,

(1999) Trends in in fectious disease mortality in the United States dur ing the 20th century,

(1987) Prospective study of the aetiology and outcome of pneumonia in the community,

(1985) Severe community- acquired pneumonia:factors influencing need of in tensive care treatment and prognosis,

(1987) Community-acquired pneumonia in adults in British hospitals in 1982-1983:a sur vey of aetiology,mortality,prognostic factors and out come,

(1989) Community-acquired pneumonia requiring hospitalization:5-year prosp ective study,

(1990) Severe community-acquired pneumonia:etiology,prognosis,and treatment,

(1997) A prediction rule to identify low-risk patients with community-acquired pneumo nia,

(1993) Guidelines for the initial management of adults with community-acq uired pneumonia:diagnosis,assessment of severity,and initial antimicrobial therapy,

10.

(2001) Guidelines for the management of adults with community-acquired pneumonia assessment of severity,

11.

(2004) Risk factors of treat ment failure in community acquired pneumonia:implications for disease outcome,

12.

(2004) Causes and factors associated with early failure in hospitalized patients with co mmunity-acquired pneumonia,

13.

(2004) Validation of the 2001 American Thoracic Society criteria for severe commu nity-acquired pneumonia,

14.

(1991) Predicting death in patients hospitalized for community-acquired pne umonia,

15.

(2001) A prospective multicenter study of commu nity-acquired pneumonia in adults with emphasis on bacterial etiology,

16.

(1991) Community acquired pneumonia:aetiology and prognostic index evaluation,

17.

(1996) Prognosis and outcomes of patients with community-acquired pneumonia:a meta-analysis,

18.

(1999) Pharmacokinetics and pha rmacodynamics of fluoroquinolones in the respiratory tract,

19.

(1992) Bronchoalveolar distribution of cefuroxime axetil and in-vitro efficacy of observed concentrations against respiratory pathogens,

20.

(1996) Distribution of cefdinir,a third generation cephalosporin antibiotic,in serum and pulmonary compartments,

21.

(1995) Antibiotic penetration into the respiratory tract:a basis for rational therapy,

22.

(1999) Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia,

23.

(2002) Randomized controlled trial of sequential intravenous and oral moxifloxacin compared with sequential i and oral co-amoxiclav with or without clarithromycin in patients with co mmunity-acquired pneumonia requiring initial par enteral treatment, Finch R

24.

(2001) Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia,

25.

(2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock,

바로가기메뉴

Article Contents

Vol.58 No.6

Factors Associated with Early Death in Patients with Community-Acquired Pneumonia

Abstract

Reference

Tuberculosis & Respiratory Diseases